EUROPE RESEARCH ROUNDUP-Adyen NV, Beazley, Nel ASA Aug 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adyen NV, Beazley and Nel ASA, on Friday. HIGHLIGHTS * Adyen NV ADYEN.AS : TD Cowen raises target price to EUR 1,620 from EUR 1,618 * Beazley BEZG.L : HSBC raises target price to 780p from 665p * Diageo DGE.L : HSBC cuts target price to 3,000p from 3,300p * Nel ASA NEL.OL : Berenberg cuts to hold from buy * ThyssenKrupp Nucera

EUROPE RESEARCH ROUNDUP- Euronext, Pearson, Saint-Gobain July 30 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Euronext, Pearson and Saint-Gobain on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : HSBC cuts target price to EUR 1600 from EUR 1900 * Deutsche Boerse AG DB1Gn.DE : JP Morgan raises target price to EUR 198 from EUR 194 * Euronext NV ENX.PA : JP Morgan cuts target price to EUR 107 from EUR 108 * Pearson PSON.L : JP Morgan cut

Italy - Factors to watch on July 30 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Chinese President Xi Jinping and Italian Prime Minister Giorgia Meloni discussed the war in Ukraine and the crisis in the Middle East at a meeting in Beijing on Monday, Meloni's office said.

UPDATE 1-DiaSorin raises 2024 guidance slightly following Q2 results Adds revenue and adj. core profit in paragraph 3-4, shares movement in 5 July 29 (Reuters) - Italian medical diagnostics group DiaSorin DIAS.MI raised its guidance slightly for 2024 after reporting on Monday a 9% rise in second-quarter adjusted core profit. The company said it now expects revenue growth this year of between 6%-7% compared to previous guidance of 5%-7% growth, and sees its 2024 adjusted core profit margin at abo

DiaSorin slightly raises 2024 guidance following Q2 results July 29 (Reuters) - Italian medical diagnostics group DiaSorin DIAS.MI on Monday slightly hiked guidance for 2024, after its second quarter adjusted core profit rose 9% at a constant exchange rate compared to the same period last yea. The company now expects for 2024 a growth in revenue excluding Covid between 6%-7% compared to previous guidance of 5%-7% growth, and sees its 2024 adjusted core profit margin at about 33% compared to a pr